Given that GSK3α silencing by RNAi has been described to induce cell differentiation5, we stained HL60 cells with α-CD11b to assess the ability of tivantinib and LiCl to differentiate AML cells by flow cytometry. The gene discussed is GSK3A; the disease is acute myeloid leukemia.